Tetrathiomolybdate
Idiopathic Pulmonary Fibrosis
Clinical trials
1
Developer
University of Michigan
Overview
Tetrathiomolybdate is an agent tracked by PF-Atlas in the context of idiopathic pulmonary fibrosis. It appears in 1 tracked IPF clinical trial.
Tetrathiomolybdate clinical trials
Explore related
Medical disclaimer. This page summarizes research about Tetrathiomolybdate for information only. It is not medical advice. Verify approval status and evidence with the FDA and a pulmonologist.